Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
0(0%)
Results Posted
11%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_1
10
100%

Phase Distribution

10

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
10(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(9)
Terminated(1)

Detailed Status

Completed9
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
90.0%
Most Advanced
Phase 1

Trials by Phase

Phase 110 (100.0%)

Trials by Status

terminated110%
completed990%

Recent Activity

0 active trials
Showing 5 of 10
completedphase_1

Pharmacokinetics, Safety and Tolerability of Concurrent Doses of BIA 5-1058 and Furosemide

NCT07173738
completedphase_1

Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Sildenafil

NCT04994860
completedphase_1

Effect of BIA 5-1058 400 mg on Warfarin Pharmacokinetics

NCT04994119
terminatedphase_1

Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058

NCT04991194
completedphase_1

Effect of Food on BIA 5-1058

NCT04991155
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07173738Phase 1

Pharmacokinetics, Safety and Tolerability of Concurrent Doses of BIA 5-1058 and Furosemide

Completed
NCT04994860Phase 1

Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Sildenafil

Completed
NCT04994119Phase 1

Effect of BIA 5-1058 400 mg on Warfarin Pharmacokinetics

Completed
NCT04991194Phase 1

Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058

Terminated
NCT04991155Phase 1

Effect of Food on BIA 5-1058

Completed
NCT04991207Phase 1

Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan

Completed
NCT03489005Phase 1

Effect of BIA 5 1058 on Cardiac Repolarization

Completed
NCT03708146Phase 1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 5-1058

Completed
NCT04675944Phase 1

Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil

Completed
NCT02151994Phase 1

Safety, Tolerability, Pharmacokinetic, Including Food Interaction, and Pharmacodynamic Profile of BIA 5-1058.

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10